Quotes 5-day view Delayed Swiss Exchange
04/01/2021
04/06/2021
04/07/2021
04/08/2021
04/09/2021
Date
305.4(c)
305.3(c)
302.2(c)
307.15(c)
309.65(c)
Last
961 132
1 003 282
1 326 517
1 164 061
1 021 222
Volume
-0.02%
-0.03%
-1.02%
+1.64%
+0.81%
Change
Sales 2021
60 335 M
65 234 M
65 234 M
Net income 2021
14 738 M
15 935 M
15 935 M
Net cash position 2021
4 797 M
5 187 M
5 187 M
P/E ratio 2021
17,8x
Yield 2021
3,05%
Sales 2022
62 347 M
67 410 M
67 410 M
Net income 2022
15 890 M
17 180 M
17 180 M
Net cash position 2022
12 336 M
13 338 M
13 338 M
P/E ratio 2022
16,7x
Yield 2022
3,16%
Capitalization
267 B
288 B
288 B
EV / Sales 2021
4,34x
EV / Sales 2022
4,08x
Nbr of Employees
101 465
Free-Float
82,6%
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The...
Notations Surperformance© of Roche Holding AG
Trading Rating :
Investor Rating :
All news about ROCHE HOLDING AG
News in other languages on ROCHE HOLDING AG
Analyst Recommendations on ROCHE HOLDING AG
ROCHE HOLDING AG - 2020
Close to an important medium term support level
BUY
Roche buys GenMark for $1.8 million to challenge test rivals
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ROCHE HOLDING AG
Short Term Mid-Term Long Term Trends Neutral Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
26
Average target price
353,44 CHF
Last Close Price
309,65 CHF
Spread / Highest target
42,4%
Spread / Average Target
14,1%
Spread / Lowest Target
-6,35%
Please enable JavaScript in your browser's settings to use dynamic charts.